NO763947L - Fremgangsm}te til } minske dosen av en biologisk aktiv substans under bibeholdelse av den biologiske effekt - Google Patents

Fremgangsm}te til } minske dosen av en biologisk aktiv substans under bibeholdelse av den biologiske effekt

Info

Publication number
NO763947L
NO763947L NO763947A NO763947A NO763947L NO 763947 L NO763947 L NO 763947L NO 763947 A NO763947 A NO 763947A NO 763947 A NO763947 A NO 763947A NO 763947 L NO763947 L NO 763947L
Authority
NO
Norway
Prior art keywords
biological
dosage
procedures
maintaining
reduce
Prior art date
Application number
NO763947A
Other languages
English (en)
Other versions
NO146974C (no
NO146974B (no
Inventor
Kjell Gunnar Blixt
Rolf Juhlin
Mandayam Tiru
Original Assignee
Kockums Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kockums Chem filed Critical Kockums Chem
Publication of NO763947L publication Critical patent/NO763947L/no
Publication of NO146974B publication Critical patent/NO146974B/no
Publication of NO146974C publication Critical patent/NO146974C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/046Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a non-organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/651The particulate/core comprising inorganic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO763947A 1976-06-29 1976-11-18 Fremgangsmaate til aa minske mengden av en biologisk aktiv substans under bibeholdelse av den biologiske effekt NO146974C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (sv) 1976-06-29 1976-06-29 Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans

Publications (3)

Publication Number Publication Date
NO763947L true NO763947L (no) 1977-12-30
NO146974B NO146974B (no) 1982-10-04
NO146974C NO146974C (no) 1983-01-26

Family

ID=20328328

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763947A NO146974C (no) 1976-06-29 1976-11-18 Fremgangsmaate til aa minske mengden av en biologisk aktiv substans under bibeholdelse av den biologiske effekt

Country Status (24)

Country Link
JP (1) JPS533512A (no)
AR (1) AR221686A1 (no)
AU (1) AU2611177A (no)
BE (1) BE848892A (no)
CA (1) CA1080500A (no)
DD (1) DD130984A5 (no)
DE (1) DE2652163A1 (no)
DK (1) DK518476A (no)
ES (1) ES460159A1 (no)
FI (1) FI61637C (no)
FR (1) FR2356430A1 (no)
GB (1) GB1572718A (no)
GR (1) GR63669B (no)
IL (1) IL52243A (no)
IN (1) IN145766B (no)
IT (1) IT1064524B (no)
LU (1) LU76238A1 (no)
MC (1) MC1116A1 (no)
NL (1) NL7613404A (no)
NO (1) NO146974C (no)
PL (1) PL199237A1 (no)
PT (1) PT66663B (no)
SE (1) SE421042B (no)
ZA (1) ZA773259B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026093B2 (ja) * 1978-03-14 1985-06-21 住友製薬株式会社 ゲフアルナート含有固型製剤の製造方法
IT1103817B (it) * 1978-06-27 1985-10-14 Guaber Spa Composizione deodorante granulare per posacenere
IT1144023B (it) * 1979-12-21 1986-10-29 Glaxo Group Ltd Mescola contenente cefalessina da incapsulare e relativo procedimento di produzione
DK204682A (da) * 1981-05-08 1982-11-09 Wellcome Found Parfumeafgivende materiale
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
HU191245B (en) * 1984-01-06 1987-01-28 Egis Gyogyszergyar,Hu Process for the production of stbale pharmaceutical preparation against ketosis
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
DE3563416D1 (en) * 1985-09-02 1988-07-28 Artesan Pharma Gmbh Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
DE19506141A1 (de) 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
AU2893097A (en) * 1996-04-29 1997-11-19 Agricultural Academy Of Krakow Oral delivery form having a high absorption efficiency and method for making same
SG71877A1 (en) 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
EP1104290B1 (en) * 1998-08-13 2010-03-31 Cima Labs Inc. Microemulsions as solid dosage forms for oral administration
PL2421508T3 (pl) * 2009-04-24 2017-06-30 Omya International Ag Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5235736B2 (no) * 1972-09-27 1977-09-10

Also Published As

Publication number Publication date
JPS533512A (en) 1978-01-13
IT1064524B (it) 1985-02-18
FI763304A (no) 1977-12-30
PT66663B (en) 1978-11-13
FI61637B (fi) 1982-05-31
ES460159A1 (es) 1978-10-01
FR2356430A1 (fr) 1978-01-27
DE2652163A1 (de) 1978-01-12
GR63669B (en) 1979-11-28
IL52243A0 (en) 1977-08-31
ZA773259B (en) 1978-04-26
PT66663A (en) 1977-07-01
NL7613404A (nl) 1978-01-02
NO146974C (no) 1983-01-26
NO146974B (no) 1982-10-04
SE421042B (sv) 1981-11-23
GB1572718A (en) 1980-07-30
FI61637C (fi) 1982-09-10
PL199237A1 (pl) 1979-07-02
IN145766B (no) 1978-12-16
AU2611177A (en) 1978-12-21
DK518476A (da) 1977-12-30
AR221686A1 (es) 1981-03-13
IL52243A (en) 1980-10-26
MC1116A1 (fr) 1977-08-12
LU76238A1 (no) 1977-05-23
FR2356430B1 (no) 1982-08-13
DD130984A5 (de) 1978-05-24
SE7607389L (sv) 1977-12-30
CA1080500A (en) 1980-07-01
BE848892A (fr) 1977-03-16

Similar Documents

Publication Publication Date Title
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
BE879918A (fr) Distributeur de medicament
NO158679C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
AT347588B (de) Arzneimittelwirkstofftraeger
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO763947L (no) Fremgangsm}te til } minske dosen av en biologisk aktiv substans under bibeholdelse av den biologiske effekt
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
DK360875A (da) Fremgangsmade til fremstilling at et legemiddel i pelletform
NO144785C (no) Instrument til dosering av stoffer inn i en kvinnes eggledere
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO147718C (no) Fremgangsmaate til fremstilling av en biologisk aktiv kopolymer
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
NO146204C (no) Fremgangsmaate til fremstilling av biologisk aktive polymerer
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
FI781866A (fi) Foerfarande foer framstaellning av terapeutiskt aktiv n-/3-merkaptoacetylamino) bensoyl/ glycin.
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO145540C (no) Fremgangsmaate for fremstilling av terapeutisk aktive polyribonukleotider
BR8009059A (pt) Administracao de substancia medicas ativas
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
SE7801106L (sv) Biologiskt aktiv substans
NO147273C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cykloheksadien-derivater
NO146776C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepiner